Hui Shi

Title: Hui Shi - Innovator in Cancer Treatment

Introduction

Hui Shi is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of acute myeloid leukemia. His innovative work focuses on developing compounds that exhibit kinase inhibitory activity.

Latest Patents

Hui Shi holds 1 patent for his invention titled "Pyrido-pyrazinyl compounds for treating acute myeloid leukemia." This patent presents compounds that have a structure represented by a specific formula. The compounds developed by Hui Shi demonstrate good inhibitory activity against various kinases, including ALK, AXL, EGFR, and FLT3. These compounds can be utilized in preparing pharmaceutical compositions aimed at treating kinase activity-related diseases, such as acute myeloid leukemia.

Career Highlights

Hui Shi is associated with Cytosinlab Therapeutics Co., Ltd., where he continues to advance his research and development efforts. His work is pivotal in the ongoing fight against cancer, showcasing his commitment to improving patient outcomes through innovative therapies.

Collaborations

Hui Shi collaborates with talented individuals in his field, including Haiping Wu and Meng Wang. Their combined expertise contributes to the success of their projects and the advancement of cancer treatment options.

Conclusion

Hui Shi's contributions to the field of cancer treatment through his innovative compounds highlight the importance of research and development in pharmaceuticals. His work not only showcases his inventiveness but also offers hope for patients battling acute myeloid leukemia.